Zoliflodacin has exhibited low cross-resistance with FQ-resistant and ceftriaxone- and azithromycinresistant in strains of N gonorrhoeae around the world. Here is a review of this recently approved antibiotic.
Jessica Ding, BS
Advertisement
Ding is an internal medicine-primary care resident at Brown University’s Rhode Island Hospital. Her interests include infectious diseases, HIV primary care, and women’s health.
Articles by Jessica Ding, BS
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Contagion Live
1
AI Model Designs Potent Antibiotics Against WHO Priority Pathogens in Minutes
2
FDA Authorizes First Multiplex PCR Assay for HSV, VZV, and Mpox Skin Lesions
3
The Latest on the Cyclosporiasis Outbreak: An FDA False Positive Test, and What Treatment Looks Like
4
Finding the Balance: Ruling Out Endocarditis in Enterococcal Bacteremia
5